Streetbeat News

Price Targets

AMAT

TD Cowen analyst Krish Sankar has maintained an Outperform rating on Applied Materials (NASDAQ:AMAT) and increased the price target from $165 to $185. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:47 pm

HUM

Argus Research analyst David Toung has upgraded Humana (NYSE:HUM) from Hold to Buy and set a price target of $550 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:47 pm

AMAL

JP Morgan analyst Steven Alexopoulos upgraded Amalgamated Financial (NASDAQ:AMAL) from Neutral to Overweight and set a price target of $29.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:45 pm

ORCL

UBS analyst Karl Keirstead has maintained a Buy rating on Oracle (NYSE:ORCL) but has reduced the price target from $135 to $125.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:45 pm

HSIC

JP Morgan analyst Rachel Vatnsdal has upgraded Henry Schein (NASDAQ:HSIC) from Neutral to Overweight and increased the price target from $71 to $82, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:44 pm

AOS

Northcoast Research analyst Kevin Hocevar upgraded A.O. Smith (NYSE:AOS) from Neutral to Buy and set a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:36 pm

ALB

B of A Securities analyst Matthew DeYoe upgraded Albemarle (NYSE:ALB) from Underperform to Neutral, while also lowering the price target from $154 to $149.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:34 pm

DOGEUSD

Crypto analyst Ali has indicated a potential correction for Dogecoin (DOGE), with the TD Sequential indicator showing a sell signal on its weekly chart. The analyst suggests that DOGE could drop to $0.085 or $0.078, but if it surpasses $0.11, the bearish outlook may be invalidated. Another analyst, Captain Faibik, has a bullish view, predicting a rise to $0.70. Currently, DOGE is trading at $0.096, down 0.51%.

Portfolio Pulse from Mehab Qureshi

December 12, 2023 | 12:30 pm

DGX

B of A Securities analyst Derik De Bruin upgraded Quest Diagnostics (NYSE:DGX) from Neutral to Buy and increased the price target from $140 to $160, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:28 pm

TXG

B of A Securities analyst Derik De Bruin upgraded 10x Genomics (NASDAQ:TXG) from Underperform to Neutral and increased the price target from $36 to $54.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:27 pm